Company profile

Monopar Therapeutics insider acquisitions

Company CIK 0001645469 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
MNPR · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.STARR CHRISTOPHER MSTARR CHRISTOPHER MCittadine AndrewCittadine AndrewRobinson ChandlerRobinson ChandlerVu Quan AnhVu Quan AnhKLAUSNER ARTHUR JKLAUSNER ARTHUR JAnderson RaymondAnderson RaymondTalukdar LavinaTalukdar LavinaTsuchimoto Kim RTsuchimoto Kim RSTARR CHRISTOPHER M · October 1, 2026 · Exercise / conversion · Common StockCittadine Andrew · September 30, 2026 · Exercise / conversion · Common StockRobinson Chandler · September 30, 2026 · Exercise / conversion · Common StockVu Quan Anh · September 30, 2026 · Exercise / conversion · Common StockVu Quan Anh · December 26, 2025 · Purchase · Common StockKLAUSNER ARTHUR J · December 16, 2025 · Other acquisition · Common StockCittadine Andrew · December 2, 2025 · Stock award · Restricted Stock UnitsCittadine Andrew · December 2, 2025 · Stock award · Stock OptionsSTARR CHRISTOPHER M · December 2, 2025 · Stock award · Stock OptionsKLAUSNER ARTHUR J · December 2, 2025 · Stock award · Stock OptionsAnderson Raymond · December 2, 2025 · Stock award · Stock OptionsTalukdar Lavina · December 2, 2025 · Stock award · Stock OptionsTsuchimoto Kim R · December 2, 2025 · Stock award · Stock OptionsVu Quan Anh · December 2, 2025 · Stock award · Restricted Stock UnitsVu Quan Anh · December 2, 2025 · Stock award · Stock OptionsRobinson Chandler · December 2, 2025 · Stock award · Restricted Stock UnitsRobinson Chandler · December 2, 2025 · Stock award · Stock OptionsDec 2, 2025Oct 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

17 dated transactions · 8 of 8 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 1, 2026Monopar TherapeuticsCommon StockSTARR CHRISTOPHER MExercise / conversion
Sep 30, 2026Monopar TherapeuticsCommon StockCittadine AndrewExercise / conversion
Sep 30, 2026Monopar TherapeuticsCommon StockRobinson ChandlerExercise / conversion
Sep 30, 2026Monopar TherapeuticsCommon StockVu Quan AnhExercise / conversion
Dec 26, 2025Monopar TherapeuticsCommon StockVu Quan AnhPurchase
Dec 16, 2025Monopar TherapeuticsCommon StockKLAUSNER ARTHUR JOther acquisition
Dec 2, 2025Monopar TherapeuticsRestricted Stock UnitsCittadine AndrewStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsCittadine AndrewStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsSTARR CHRISTOPHER MStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsKLAUSNER ARTHUR JStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsAnderson RaymondStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsTalukdar LavinaStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsTsuchimoto Kim RStock award
Dec 2, 2025Monopar TherapeuticsRestricted Stock UnitsVu Quan AnhStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsVu Quan AnhStock award
Dec 2, 2025Monopar TherapeuticsRestricted Stock UnitsRobinson ChandlerStock award
Dec 2, 2025Monopar TherapeuticsStock OptionsRobinson ChandlerStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

MNPR · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Exercise / conversionCommon StockNon-derivative security · Code M8,4000.005Value: 42Currency not specifiedView ↗
Trade:
Cittadine AndrewChief Operating Officer
Exercise / conversionCommon StockNon-derivative security · Code M4,384Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Robinson ChandlerChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M9,801Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Vu Quan AnhChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M614Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Vu Quan AnhChief Financial Officer
PurchaseCommon StockNon-derivative security · Code P1,50069.95Value: 104,925Currency not specifiedView ↗
Trade: Other acquisitionCommon StockNon-derivative security · Code J7,7100Value: 0Currency not specifiedView ↗
Trade:
Cittadine AndrewChief Operating Officer
Stock awardRestricted Stock UnitsDerivative security · Code A13,9190Value: 0Currency not specifiedView ↗
Trade:
Cittadine AndrewChief Operating Officer
Stock awardStock OptionsDerivative security · Code A8,9690Value: 0Currency not specifiedView ↗
Trade: Stock awardStock OptionsDerivative security · Code A2,9240Value: 0Currency not specifiedView ↗
Trade: Stock awardStock OptionsDerivative security · Code A2,9240Value: 0Currency not specifiedView ↗
Trade: Stock awardStock OptionsDerivative security · Code A2,9240Value: 0Currency not specifiedView ↗
Trade: Stock awardStock OptionsDerivative security · Code A2,9240Value: 0Currency not specifiedView ↗
Trade: Stock awardStock OptionsDerivative security · Code A2,9240Value: 0Currency not specifiedView ↗
Trade:
Vu Quan AnhChief Financial Officer
Stock awardRestricted Stock UnitsDerivative security · Code A9,8260Value: 0Currency not specifiedView ↗
Trade:
Vu Quan AnhChief Financial Officer
Stock awardStock OptionsDerivative security · Code A7,1350Value: 0Currency not specifiedView ↗
Trade:
Robinson ChandlerChief Executive Officer · Director
Stock awardRestricted Stock UnitsDerivative security · Code A49,1330Value: 0Currency not specifiedView ↗
Trade:
Robinson ChandlerChief Executive Officer · Director
Stock awardStock OptionsDerivative security · Code A16,7530Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →